1. 1903. Cost Minimization Analysis of a Preferred ARV Prescribing Pathway for Treatment-Naïve HIV-Positive Patients. (26th November 2018) Authors: Kerr, Colm; Allen, Niamh; Moynan, David; Moriarty, Miriam; Murphy, Sinead; Farrell, Gillian; Bergin, Colm Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin. Issue 3 (2nd August 2020) Authors: Kelly, Mary; O'Connor, Ròisìn; Townsend, Liam; Coghlan, Miriam; Relihan, Eileen; Moriarty, Miriam; Carr, Bernard; Melanophy, Gail; Doyle, Caitriona; Bannan, Ciaran; O'Riordan, Ruth; Merry, Concepta; Clarke, Susie; Bergin, Colm Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 3(2021) Page Start: 1150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Delayed haemolysis after IV artesunate therapy for P. falciparum infection. Issue 45 (January 2022) Authors: O'Connor, Ròisìn; Conlan, Ciara; Grant, Conor; Kinsella, Nora; Moriarty, Miriam; Carr, Bernard; Melanophy, Gail; Doyle, Caitriona; Merry, Concepta; Bannan, Ciaran; Bergin, Colm Journal: Travel medicine and infectious disease Issue: Issue 45(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗